Can-Fite BioPharma Ltd. (CANF)
NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
At close: 03:32PM EDT
| Previous Close | 2.0900 |
| Open | 2.3200 |
| Bid | 2.0700 x 1400 |
| Ask | 2.2200 x 2200 |
| Day's Range | 2.1100 - 2.2599 |
| 52 Week Range | 1.8100 - 3.3300 |
| Volume | |
| Avg. Volume | 18,131 |
| Market Cap | 10.53M |
| Beta (5Y Monthly) | 0.91 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Can-Fite (CANF) Up on Liver Cancer Study Update of Namodenoson
Can-Fite (CANF) stock up 7% as the liver cancer patient achieves a complete response and overall survival of 6.9 years upon continued treatment with namodenoson in a phase II study.
- Zacks
Can-Fite Biopharma Ltd (CANF) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
After losing some value lately, a hammer chart pattern has been formed for Can-Fite Biopharma Ltd (CANF), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
- Zacks
Best Momentum Stocks to Buy for October 27th
VRT, PGR and CANF made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on October 27, 2023.
© 2024 Yahoo. All rights reserved.